JP2023513655A5 - - Google Patents
Info
- Publication number
- JP2023513655A5 JP2023513655A5 JP2022525958A JP2022525958A JP2023513655A5 JP 2023513655 A5 JP2023513655 A5 JP 2023513655A5 JP 2022525958 A JP2022525958 A JP 2022525958A JP 2022525958 A JP2022525958 A JP 2022525958A JP 2023513655 A5 JP2023513655 A5 JP 2023513655A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- independently
- compound according
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025054317A JP2025118594A (ja) | 2019-11-08 | 2025-03-27 | アポトーシス阻害(iap)タンパク質アンタゴニスト |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962933190P | 2019-11-08 | 2019-11-08 | |
| US62/933,190 | 2019-11-08 | ||
| PCT/US2020/059552 WO2021092500A1 (en) | 2019-11-08 | 2020-11-06 | Inhibitor of apoptosis (iap) protein antagonists |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025054317A Division JP2025118594A (ja) | 2019-11-08 | 2025-03-27 | アポトーシス阻害(iap)タンパク質アンタゴニスト |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023513655A JP2023513655A (ja) | 2023-04-03 |
| JP2023513655A5 true JP2023513655A5 (https=) | 2023-10-18 |
| JP7659553B2 JP7659553B2 (ja) | 2025-04-09 |
Family
ID=75849612
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022525958A Active JP7659553B2 (ja) | 2019-11-08 | 2020-11-06 | アポトーシス阻害(iap)タンパク質アンタゴニスト |
| JP2025054317A Pending JP2025118594A (ja) | 2019-11-08 | 2025-03-27 | アポトーシス阻害(iap)タンパク質アンタゴニスト |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025054317A Pending JP2025118594A (ja) | 2019-11-08 | 2025-03-27 | アポトーシス阻害(iap)タンパク質アンタゴニスト |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230115837A1 (https=) |
| EP (1) | EP4058454A4 (https=) |
| JP (2) | JP7659553B2 (https=) |
| AU (1) | AU2020380818A1 (https=) |
| CA (1) | CA3160666A1 (https=) |
| WO (1) | WO2021092500A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020110056A1 (en) * | 2018-11-30 | 2020-06-04 | Glaxosmithkline Intellectual Property Development Limited | Compounds useful in hiv therapy |
| CA3160666A1 (en) * | 2019-11-08 | 2021-05-14 | Sanford Burnham Prebys Medical Discovery Institute | Inhibitor of apoptosis (iap) protein antagonists |
| AU2021265826B2 (en) * | 2020-04-30 | 2026-03-19 | Sanford Burnham Prebys Medical Discovery Institute | Inhibitor of apoptosis (IAP) protein antagonists |
| CN117304253A (zh) * | 2022-06-22 | 2023-12-29 | 中国药科大学 | 一种二氮杂双环拟肽衍生物的制备方法及应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8202902B2 (en) * | 2006-05-05 | 2012-06-19 | The Regents Of The University Of Michigan | Bivalent SMAC mimetics and the uses thereof |
| NZ572531A (en) * | 2006-05-05 | 2011-09-30 | Univ Michigan | Bivalent smac mimetics and the uses thereof |
| US20100317593A1 (en) * | 2009-06-12 | 2010-12-16 | Astrazeneca Ab | 2,3-dihydro-1h-indene compounds |
| US8551955B2 (en) * | 2009-10-28 | 2013-10-08 | Joyant Pharmaceuticals, Inc. | Dimeric Smac mimetics |
| US9546174B2 (en) * | 2012-11-30 | 2017-01-17 | Sanford-Burnham Medical Research Institute | Inhibitor of apoptosis protein (IAP) antagonists |
| JP6768522B2 (ja) * | 2014-06-04 | 2020-10-14 | サンフォード−バーンハム メディカル リサーチ インスティテュート | Hiv治療におけるアポトーシスタンパク質阻害剤(iap)のアンタゴニストの使用 |
| KR20180107261A (ko) * | 2016-02-16 | 2018-10-01 | 메사추세츠 인스티튜트 오브 테크놀로지 | Myc 조정제로서의 MAX 결합제 및 그의 용도 |
| US10870663B2 (en) * | 2018-11-30 | 2020-12-22 | Glaxosmithkline Intellectual Property Development Limited | Compounds useful in HIV therapy |
| WO2020110056A1 (en) * | 2018-11-30 | 2020-06-04 | Glaxosmithkline Intellectual Property Development Limited | Compounds useful in hiv therapy |
| CA3160666A1 (en) * | 2019-11-08 | 2021-05-14 | Sanford Burnham Prebys Medical Discovery Institute | Inhibitor of apoptosis (iap) protein antagonists |
-
2020
- 2020-11-06 CA CA3160666A patent/CA3160666A1/en active Pending
- 2020-11-06 JP JP2022525958A patent/JP7659553B2/ja active Active
- 2020-11-06 US US17/773,749 patent/US20230115837A1/en active Pending
- 2020-11-06 EP EP20886024.7A patent/EP4058454A4/en active Pending
- 2020-11-06 WO PCT/US2020/059552 patent/WO2021092500A1/en not_active Ceased
- 2020-11-06 AU AU2020380818A patent/AU2020380818A1/en active Pending
-
2025
- 2025-03-27 JP JP2025054317A patent/JP2025118594A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023513655A5 (https=) | ||
| RU2495044C2 (ru) | Ингибиторы активности протеинтирозинкиназы | |
| EA201070871A1 (ru) | Бициклические производные азабициклических карбоксамидов, их получение и их применение в терапии | |
| JP2021513534A5 (https=) | ||
| DE602004019198D1 (de) | Chinolin-2-on-derivate zur behandlung von erkankungen der atemwege | |
| EA202090553A1 (ru) | Производные 3-(1-оксоизоиндолин-2-ил)пиперидин-2,6-диона и варианты их применения | |
| RU2488582C2 (ru) | Бициклозамещенные азопроизводные пиразолона, способ их получения и фармацевтическое применение | |
| JP2020534361A5 (https=) | ||
| JP2014500870A5 (https=) | ||
| JP2010530372A5 (https=) | ||
| CY1117576T1 (el) | Δινουκλεοτιδικα προφαρμακα | |
| RU2013152132A (ru) | Борсодержащие малые молекулы в качестве противовоспалительных средств | |
| CY1116119T1 (el) | Παραγωγα ισοξαζολο-πυριδινης | |
| JP2010504346A5 (https=) | ||
| RU2010140627A (ru) | Производные пирролидина | |
| DE602007008616D1 (de) | Verfahren zur herstellung von 4'-azidocytidinderivaten | |
| ATE547417T1 (de) | Dihydropyrimidinverbindungen und ihre verwendungen bei der herstellung von medikamenten zur behandlung und prävention antiviraler krankheiten | |
| FI3546462T3 (fi) | Uusi oksoisokinoliinijohdannainen | |
| CY1114865T1 (el) | Νεοι αναστολεις seh και η χρηση toyς | |
| JP2013533253A5 (https=) | ||
| JP2016531126A5 (https=) | ||
| RU2012155118A (ru) | Способы лечения биполярного расстройства | |
| JP2020531526A5 (https=) | ||
| JP2018529690A5 (https=) | ||
| JP2019527724A5 (https=) |